• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项生物信息学分析揭示新型病原体是系统性硬化症分子模拟的触发因素。

A Bioinformatics Analysis Reveals Novel Pathogens as Molecular Mimicry Triggers of Systemic Sclerosis.

作者信息

Gkoutzourelas Athanasios, Barmakoudi Maria, Bogdanos Dimitrios P

机构信息

Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

出版信息

Mediterr J Rheumatol. 2020 Mar 31;31(1):50-70. doi: 10.31138/mjr.31.1.50. eCollection 2020 Mar.

DOI:10.31138/mjr.31.1.50
PMID:32411933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7219639/
Abstract

A recent bioinformatic analysis revealing dominant B cell epitopes of systemic sclerosis-specific autoantibodies, including anti-centromere B, anti-topoisomerase I and anti-fibrillarin, has demonstrated the existence of several in silico antigenic mimics of pathogens that could act as triggers of the respective dominant autoepitopes. Based on those findings, the aim of the present study was to use a more comprehensive bioinformatic analysis. We demonstrated the presence of a plethora of novel microbial mimics, unnoticed by the studies so far conducted, which share remarkable amino acid similarities with the respective autoantigenic epitopes. This bioinformatic approach coupled by in vitro testing of the homologous self/non-self-mimics in serum samples from patients with systemic sclerosis may provide novel evidence of immunological cross-reactivity, implicating currently ignored or overlooked pathogens, which may indeed play a role in the induction of SSc-specific autoantibodies and assist efforts to understand the pathogenesis of this enigmatic disease.

摘要

最近一项生物信息学分析揭示了系统性硬化症特异性自身抗体(包括抗着丝粒B抗体、抗拓扑异构酶I抗体和抗核仁纤维蛋白抗体)的主要B细胞表位,证明存在几种病原体的计算机模拟抗原,它们可能是各自主要自身表位的触发因素。基于这些发现,本研究的目的是进行更全面的生物信息学分析。我们证明了存在大量迄今为止的研究所未发现的新型微生物模拟物,它们与各自的自身抗原表位具有显著的氨基酸相似性。这种生物信息学方法,再结合对系统性硬化症患者血清样本中的同源自身/非自身模拟物进行体外检测,可能会提供免疫交叉反应性的新证据,涉及目前被忽视或未被重视的病原体,这些病原体可能确实在系统性硬化症特异性自身抗体的诱导中起作用,并有助于努力理解这种神秘疾病的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/0f69b94c748b/MJR-31-1-50-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/f08b6bae7cc0/MJR-31-1-50-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/bca2ff39a2a7/MJR-31-1-50-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/0f69b94c748b/MJR-31-1-50-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/f08b6bae7cc0/MJR-31-1-50-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/bca2ff39a2a7/MJR-31-1-50-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e7b/7219639/0f69b94c748b/MJR-31-1-50-g003.jpg

相似文献

1
A Bioinformatics Analysis Reveals Novel Pathogens as Molecular Mimicry Triggers of Systemic Sclerosis.一项生物信息学分析揭示新型病原体是系统性硬化症分子模拟的触发因素。
Mediterr J Rheumatol. 2020 Mar 31;31(1):50-70. doi: 10.31138/mjr.31.1.50. eCollection 2020 Mar.
2
Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes.系统性硬化症和其他结缔组织疾病中存在的抗纤维原抗体与相似的表位相互作用。
J Exp Med. 1995 Mar 1;181(3):1027-36. doi: 10.1084/jem.181.3.1027.
3
Pathogenic roles of B lymphocytes in systemic sclerosis.B 淋巴细胞在系统性硬化症中的致病作用。
Immunol Lett. 2018 Mar;195:76-82. doi: 10.1016/j.imlet.2018.01.002. Epub 2018 Jan 5.
4
Disease-related autoantibody profile in patients with systemic sclerosis.系统性硬化症患者的疾病相关自身抗体谱。
Autoimmunity. 2017 Nov;50(7):414-421. doi: 10.1080/08916934.2017.1357699. Epub 2017 Jul 27.
5
Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity.人类疾病和自身免疫性小鼠模型中针对核仁纤维蛋白自身抗体反应的分析。
J Immunol. 1995 Jan 15;154(2):961-71.
6
[B cell abnormalities and therapeutic strategies in systemic sclerosis].[系统性硬化症中的B细胞异常与治疗策略]
Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):197-206. doi: 10.2177/jsci.39.197.
7
Pathogenesis of systemic sclerosis-current concept and emerging treatments.系统性硬化症的发病机制——当前概念与新兴治疗方法
Immunol Res. 2017 Aug;65(4):790-797. doi: 10.1007/s12026-017-8926-y.
8
[Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].[巴西中西部地区系统性硬化症患者的自身抗体及其临床相关性]
Rev Bras Reumatol. 2015 May-Jun;55(3):229-39. doi: 10.1016/j.rbr.2014.09.007. Epub 2014 Nov 7.
9
[Analysis of B cell autoepitopes and mechanisms for autoantibody production in autoimmune diseases].[自身免疫性疾病中B细胞自身表位分析及自身抗体产生机制]
Nihon Rinsho. 1997 Jun;55(6):1462-7.
10
[Molecular mimicry and mechanisms of autoantibody production].[分子模拟与自身抗体产生机制]
Nihon Rinsho. 1997 Jun;55(6):1370-6.

引用本文的文献

1
Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases.自身免疫性风湿性疾病发病机制中的分子模拟
J Transl Autoimmun. 2025 Jan 7;10:100269. doi: 10.1016/j.jtauto.2025.100269. eCollection 2025 Jun.
2
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases.抗核自身抗体在系统性硬化症中的致病作用:来自其他风湿性疾病的见解
Immunol Rev. 2024 Nov;328(1):265-282. doi: 10.1111/imr.13390. Epub 2024 Sep 9.
3
Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in and Prospects of Mimic-Based Vaccine Design: An In Silico Approach.

本文引用的文献

1
and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.自身抗体定义了硬皮病的亚型和非裔美国人和欧洲裔美国人的风险,并提示了分子模拟的作用。
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):552-562. doi: 10.1073/pnas.1906593116. Epub 2019 Dec 23.
2
Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease.分子模拟、遗传同源性和基因共享蛋白质组学“分子指纹”,使用 EBV(Epstein-Barr virus)衍生的微阵列作为自身免疫性疾病的潜在诊断方法。
Immunol Res. 2018 Dec;66(6):686-695. doi: 10.1007/s12026-018-9045-0.
3
挖掘自身免疫性疾病相关分子模拟候选物及基于模拟的疫苗设计前景:一种计算机模拟方法
Microorganisms. 2023 Sep 12;11(9):2300. doi: 10.3390/microorganisms11092300.
4
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?抗核抗体在系统性硬化症中是否具有致病性作用?
Front Immunol. 2022 Jun 28;13:930970. doi: 10.3389/fimmu.2022.930970. eCollection 2022.
5
Biodiversity of New Lytic Bacteriophages Infecting spp. in Freshwater Environment.感染淡水环境中 spp. 的新型裂解性噬菌体的生物多样性
Front Microbiol. 2021 Feb 17;12:619323. doi: 10.3389/fmicb.2021.619323. eCollection 2021.
6
Mediterranean Journal of Rheumatology March 2020 Highlights.《地中海风湿病学杂志》2020年3月亮点
Mediterr J Rheumatol. 2020 Mar 31;31(1):1-2. doi: 10.31138/mjr.31.1.1. eCollection 2020 Mar.
Molecular mimicry and autoimmunity.
分子模拟与自身免疫。
J Autoimmun. 2018 Dec;95:100-123. doi: 10.1016/j.jaut.2018.10.012. Epub 2018 Oct 26.
4
miPepBase: A Database of Experimentally Verified Peptides Involved in Molecular Mimicry.miPepBase:一个涉及分子模拟的经实验验证的肽数据库。
Front Microbiol. 2017 Oct 23;8:2053. doi: 10.3389/fmicb.2017.02053. eCollection 2017.
5
From microbiome to infectome in autoimmunity.自身免疫中从微生物组到感染组
Curr Opin Rheumatol. 2017 Jul;29(4):369-373. doi: 10.1097/BOR.0000000000000394.
6
Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.感染与自身免疫:人类巨细胞病毒在自身免疫性内皮细胞损伤中的作用
Lupus. 2015 Apr;24(4-5):419-32. doi: 10.1177/0961203314558677.
7
E. coli Induced Experimental Model of Primary Biliary Cirrhosis: At Last.大肠杆菌诱导的原发性胆汁性肝硬化实验模型:终于实现了。
Int J Hepatol. 2014;2014:848373. doi: 10.1155/2014/848373. Epub 2014 Dec 16.
8
Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease.生物信息学和免疫学分析表明,在克罗恩病中缺乏对麻疹病毒相关模拟的支持。
BMC Med. 2014 Aug 28;12:139. doi: 10.1186/s12916-014-0139-9.
9
Liver immunology.肝脏免疫学。
Compr Physiol. 2013 Apr;3(2):567-98. doi: 10.1002/cphy.c120011.
10
Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.分子模拟而非同一性破坏了 CYP2D6 小鼠模型中的 T 细胞耐受,该模型模拟了人类自身免疫性肝炎。
J Autoimmun. 2013 May;42:39-49. doi: 10.1016/j.jaut.2012.11.001. Epub 2012 Nov 28.